Liminal Biosciences (LMNL) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-2.15
-1.48
-0.81
-0.14

Details

Expected EPS
N/A
Actual EPS
-2.15
Surprise EPS
-2.15
Surprise Percent
+∞%

Description

Liminal Biosciences (LMNL) has reported earnings of -2.15 per share for Q2 2023.

0 Comments

Share your thoughts